Lung cancer (CG121)
Fast, easy summary view of NICE guidance on 'lung cancer'
Specific, concise statements that act as markers of high-quality, cost-effective patient care
This clinical guideline (published April 2011) updates and replaces NICE clinical guideline 24 (published February 2005). It offers evidence-based advice on the care and treatment of people with lung cancer. New and updated recommendations are included on communication, diagnosis and staging, selection of patients with non-small-cell lung cancer (NSCLC) for treatment with curative intent, surgery with curative intent for NSCLC, smoking cessation, combination treatment for NSCLC, treatment for small-cell lung cancer (SCLC), managing endobronchial obstruction, managing brain metastases, and follow-up and patient perspectives.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: lung cancer
This page was last updated: 18 September 2013
- Web format
- NICE Guideline (PDF)
- Full Guideline
- CG121 Canfod a thrin canser yr ysgyfaint: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
- Baseline assessment tool
- Clinical audit tool
- Costing report
- Costing template
- Multiple guidance audit tool
- Slide set
- Suspected lung cancer: when you should refer - online educational tool
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.